TrivarX Limited (MDBIF)
TrivarX Limited operates as a health technology enterprise, focusing on the creation of advanced, AI-driven, and scientifically validated instruments for the detection and diagnosis of behavioral health disorders. The company's reach extends across both Australia and the United States. Beyond its core diagnostic tools, TrivarX provides specialized mental well-being programs tailored for businesses as a corporate health solution, and also develops various products for the wider healthcare provider market. The firm, which was founded in 1987 and is headquartered in Mount Lawley, Australia, changed its name to TrivarX Limited in October 2023, having previously operated under the name Medibio Limited.
Sector: Medical - Healthcare Information Services
Industry: Medical - Healthcare Information Services
TrivarX Limited
- 0.0%
- 21.8K
- 1.97
Float 724.84M · FMP free float
The cost to borrow MDBIF shares for a short sale and how many IBKR has available, from IBKR's lendable-stock file, refreshed through the session.
- No fails on record for 16–31 Oct 2026.
Latest short interest settlements (today's share basis)
| Date | Shares short |
|---|---|
| Oct 15, 2026 | 21.8K sh |
| Sep 30, 2026 | 21.8K sh |
The three panels share one date axis, so a point's position is its date; each has its own value axis. Short interest is plotted on today's share basis, so the line does not step where a split does.
Too few published sessions to show a reading in context.
FINRA's weekly alternative trading system (dark pool) volume for MDBIF: the share of off-exchange volume that traded on an ATS, and each venue by shares and trades.
As of the Oct 15, 2026 FINRA settlement, 21,840 MDBIF shares were sold short (<0.01% of a 724.84M-share float, 1.97 days to cover).